Precision reprogramming iPSCs to generate a source of defined, scalable human cells



July 3, 2023

  • Share
  • See how's platform uses opti-ox technology to consistently convert stem cells into defined human cells. The resulting cells enable scalable disease research and drug discovery, with time and cost improvements over traditional technologies.

    BiopharmaDrug DiscoveryStem Cells

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.